The U.S. home healthcare market size was estimated at USD 56.93 billion in 2025 and is predicted to increase from USD 61.48 billion in 2026 to approximately USD 122.91 billion by 2035, expanding at a CAGR of 8% from 2026 to 2035. The market is growing due to the rising demand for affordable patient-centered care delivered at home, especially among the elderly and chronically ill populations. Increasing use of telehealth, remote monitoring, and home-based medical services is further supporting market expansion.
The U.S. home healthcare refers to medical and supportive care services provided to patients in their homes, including skilled nursing therapy, rehabilitation, and personal care assistance. The U.S. home healthcare market is expanding as patient increasing seek convenient treatment in familiar home settings, demand for long-term care, post-surgical recovery support, and daily assistance services is rising steadily. Healthcare providers are also focusing on improving patient outcomes through continuous monitoring and personalized care plans, while reducing pressure on hospitals and healthcare facilities, which is further supporting the growth of home healthcare services in the country.
The future of the U.S. home healthcare market is expected to be driven by increasing demand for personalized treatment, rising adoption of remote monitoring technologies, and growing preferences for home-based medical services. Expanding elderly population, continuous healthcare digitization, and the focus on reducing hospital dependency are expected to further support long-term market growth.
| Year | % of Medicare Beneficiaries Using Telehealth |
| 2020 | 48% |
| 2021 | 34% |
| 2022 | 29% |
| 2023 | 25% |
| 2024 | 25% |
According to the U.S. Centers for Medicare & Medicaid Services (CMS), telehealth adoption surged sharply in 2020 due to COVID-19, reaching nearly half of medicare beneficiaries. After this peak, usage normalized but remained stable at around 25-34% through 2024. Meanwhile, remote patient monitoring services continued to expand steadily due to CMS reimbursement support and increasing demand for chronic disease management in home healthcare settings.
The services segment held a dominant share of 59% in 2025 due to a rapidly aging baby boomer population, rising rates of chronic illnesses, and a strong preference for recovering in the comfort of home. Furthermore, at-home skilled nursing and specialized therapies are far more cost-effective than prolonged hospital stays
The cardiovascular disorder & hypertension segment led the U.S. home healthcare market with a share of 22% in 2025 due to the high prevalence of heart-related conditions and rising hypertension cases among the aging population. The increasing need for continuous monitoring, post-acute cardiac care, and long-term disease management at home is driving demand. Additionally, growing adoption of remote monitoring devices and efforts to reduce hospital readmissions further strengthen this segment’s leading position.
The skilled nursing services segment dominated the U.S. home healthcare market with a share of 28% in 2025 due to its critical role in providing medical care for elderly and chronically ill patients. Rising demand for post-surgical care, medication management, wound care, and chronic disease monitoring at home supports its leadership. Additionally, growing preference for hospital -level care in home settings and shortage of hospital capacity further strengthen the dominance of skilled nursing services.
The Medicare/Medicaid segment led the U.S. home healthcare market with a share of 49% in 2025 and is expected to grow at the fastest CAGR of 8.50% in the market during the forecast period due to strong government-backed coverage for the elderly and low-income populations. The rising prevalence of chronic diseases and long-term care needs further access to utilization of home-based services. Additionally, expanding reimbursement policies, a growing aging population, and a focus on cost-effective care delivery continue to drive rapid segment growth.
The in-home visit segment held a dominant share of 56% in 2025 due to strong patient preference for receiving personalized medical care in a familiar environment. It enables skilled nursing, therapy, and chronic disease management with better patient comfort and outcomes. Additionally, reduced hospital dependency improved access to caregivers, and the growing elderly population further supports the dominance of in-home visit services.
Leading companies in the market include Amedisys Inc., LHC Group Inc., Kindred at Home, Brookdale Senior Living Inc., and Enhabit Inc. These players are strengthening market growth through the expansion of skilled nursing services, rehabilitation therapy, and chronic disease management at home. Continuous investments in home-based care networks, partnerships with healthcare providers, and adoption of digital health and remote monitoring solutions are further enhancing their leadership in the U.S. home healthcare landscape.
By Component
By Indication
By Service Type
By Payer
By Delivery Mode
